← Back to all signals
RESEARCH PAPER ANALYSIS

Correlation analysis between plasma circulating tumour deoxyribonucleic acid variations and survival in patients with hepatocellular carcinoma.

AI interpretation is pending for this paper.

Open original publication →
PMID41743182
JournalFrontiers in oncology
Publication Date2026-02-10
Ingested2026-08-02 12:03 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

OBJECTIVE: This study aimed to analyse the variation of circulating tumour DNA (ctDNA) in patients with hepatocellular carcinoma (HCC). METHODS: Newly diagnosed patients with HCC admitted between March 2022 and October 2023 were prospectively enrolled. Plasma ctDNA testing was performed before treatment, and clinical information, treatment regimens and survival data were collected. RESULTS: A total of 166 patients with HCC were enrolled, including 127 men and 39 women, with a mean age of 58.1±10.0 years. Of these, 137 patients were infected with hepatitis B virus, and 129 had underlying cirrhosis. According to the Barcelona Clinic Liver Cancer (BCLC) staging system, 74, 20, 52 and 20 patients were classified as stages A, B, C and D, respectively. Tumour mutation burden (TMB) ranged from 0 to 35.48 mutations per Mb; it increased with higher BCLC stages but decreased in stage D. The top five mutated genes were TP53 (39.8%), CTNNB1 (15.7%), LRP1B (12.0%), ARID1A (10.8%) and FAT3 (9.0%). Patients with TP53 and LRP1B mutations exhibited shorter survival (p < 0.05). Among the 54 patients who received systemic therapy, only those with LRP1B mutations had significantly reduced overall survival (OS) (p = 0.048). Cox multivariate survival analysis revealed that TMB and Child-Pugh scores were closely associated with OS. Regardless of tumour stage, LRP1B mutation was significantly correlated with OS in patients undergoing systemic therapy. CONCLUSION: Circulating tumour DNA testing demonstrated that TMB is closely associated with OS in patients with HCC. Patients with HCC with LRP1B mutations had significantly shorter survival when receiving systemic therapy. Circulating tumour DNA testing holds considerable value in predicting HCC prognosis and may serve as a biomarker for assessing patient outcomes.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Molecular diagnostics in paediatric oncology in Latin America: findings from the Latin America Regional Advisory Committee (RAC LATAM) regional assessment. Ecancermedicalscience 54.0 2 PEDCan: acceptability and feasibility of a mobile application to support primary health-care workers in recognising clinical features of childhood cancer in Uganda. Ecancermedicalscience 59.0 3 Li-Fraumeni Syndrome: Current Perspectives on Molecular Pathogenesis, Surveillance Strategies, Clinical Management and Pediatric Considerations. Cureus 82.5 4 Mechanism-Driven Evolution of Fertility-Sparing Treatment and Precision Management of Special Populations in Endometrial Cancer: A Review. Cancers 85.09 5 Exposure to Particulate Matter (PM) During Pregnancy and Non-Hodgkin Lymphomas in Children. Cancers 69.5 6 Whole-Body MRI Versus 18F-FDG-PET/CT for the Detection of Nodal and Distant Metastases in Pediatric Patients with Solid Tumors. Cancers 70.9 7 Prehabilitation Practices for Paediatric Haematopoietic Stem Cell Transplantation: A Survey and Patient and Public Involvement Study of Healthcare Professionals. Nutrients 62.2 8 Comparison of Radiological and Postoperative Tumor Volume Measurements for SIOP Risk Stratification in Wilms Tumord. Diagnostics (Basel, Switzerland) 59.9 9 Neurofilament Light Chain: A Potential Biomarker for Chemotherapy-Induced Peripheral Neuropathy in Pediatric and Adolescent Young Adults with Leukemia or Lymphoma. Cancers 73.59 10 Immune Modulation in Peripheral Blood of Cystic Fibrosis Patients Following Ex Vivo Co-Culture with Mesenchymal Stem Cells. Cells 61.2 11 The Gut-Brain Axis and Dietary Patterns in Shaping Long-Term Neurocognitive and Psychosocial Outcomes in Adolescent and Young Adult Survivors of Childhood Cancer: A Systematized Narrative Review. Nutrients 85.6 12 Association of Recorded Cerebrospinal Fluid Diversion with Registry Outcome Status in Pediatric Medulloblastoma: An Exploratory 10-Year Single-Centre Cohort Study. Journal of clinical medicine 66.1 13 Changes in Ultrasound-Based Risk Stratification and Surgical Selection of Adnexal Masses During the COVID-19 Pandemic: A Single-Center Retrospective Study. Diagnostics (Basel, Switzerland) 65.4 14 Multi-Target HCC Blood Test Demonstrates Consistent Performance Across Subgroups of Patients with Chronic Liver Disease. Cancers 67.0 15 Pediatric Mycosis Fungoides and Hydroa Vacciniforme Lymphoproliferative Disorder. Cancers 62.3 16 Silent Verb Generation During fMRI Reveals Post-Radiotherapy Alterations in Cerebellar-Cerebral Language Regions in Patients Treated for Medulloblastoma. Cancers 71.24 17 Evaluating the Prognostic Relevance of Pre-Treatment Epstein-Barr Virus Levels in Non-Endemic Pediatric Nasopharyngeal Carcinoma. Cancers 70.34 18 Severe Suprasystemic Refractory Pulmonary Hypertension in a Neonate with Stüve-Wiedemann Syndrome Associated with Biallelic LIFR Variants: Molecular Insights and a Neonatal Case Report. International journal of molecular sciences 51.12 19 Clinical Outcome and Prognostic Factors in Childhood Acute Lymphoblastic Leukemia-A Retrospective Cohort Study of Patients from Southern Mexico. Journal of clinical medicine 70.3 20 Case Report: Single-cell transcriptomic profiling of a pediatric ALK-negative gastric inflammatory myofibroblastic tumor. Frontiers in immunology 45.5 21 Case Report: Mixed gonadal dysgenesis with Müllerian remnants mimicking a prostatic utricle in a child with 45,X/46,XY/47,XYY mosaicism. Frontiers in pediatrics 49.0 22 Sodium fluorescein in pediatric brain tumor surgery: a retrospective volumetric analysis of resection extent and consistency. Frontiers in surgery 56.0 23 Electromagnetic Surgical Navigation for Accurate Pediatric Tumor Localization: A Preclinical Animal Cadaver Study. Cancers 59.6 24 T-lymphoblastic leukemia/lymphoma: a comprehensive review of pathology, molecular features, and differential diagnosis. Journal of pathology and translational medicine 64.0 25 Family Bonds at the End of Life: A Qualitative Study of Meaning Reconstruction Through Intergenerational Relationships Among Older Adults With Advanced Lung Cancer. Psycho-oncology 57.5 26 Scenario-Related Anxiety, Self-Reported Critical Incidents, and Burnout Among Anesthesia Professionals: A Cross-Sectional Survey. Healthcare (Basel, Switzerland) 59.0 27 Research Progress on Angiogenesis and Involution Mechanisms of Infantile Hemangioma and Its Regulation by Active Components of Salvia miltiorrhiza. International journal of molecular sciences 59.75 28 Nutritional Prevention of Oxidative Stress-Induced Cardiotoxicity in Pediatric Cardio-Oncology: Molecular Mechanisms and Translational Perspectives-A Narrative Review. International journal of molecular sciences 72.37 29 Perceived Facilitators and Barriers Inform Young Adult Cancer Survivors' Preferences for Physical Activity and Diet Interventions: A Qualitative Study. Nutrients 62.2 30 Three-Dimensional Left Ventricle Strain Echocardiography in the Detection of Anthracycline Cardiotoxicity in Children with Acute Lymphoblastic Leukemia-Retrospective Case-Control Analysis and Relation to the Cardiotoxicity Risk Factors Assessment. Cancers 70.22 31 Chemotherapy-Mediated Purging Before Testicular Organoid Generation Significantly Reduces Cancer Cells While Not Significantly Reducing Germ Cells. International journal of molecular sciences 63.34 32 Phenotype-Specific Pharmacogenetic Patterns of Methotrexate Neurotoxicity in Pediatric Acute Lymphoblastic Leukemia. Journal of clinical medicine 67.02
PATIENT-FRIENDLY SUMMARY

Correlation analysis between plasma circulating tumour deoxyribonucleic acid variations and survival in patients with hepatocellular carcinoma.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic